120 related articles for article (PubMed ID: 12352321)
1. Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure.
Nishida M; Ieshima M; Konishi F; Yamashita J; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2002 Oct; 40(4):586-93. PubMed ID: 12352321
[TBL] [Abstract][Full Text] [Related]
2. Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats.
Kuro T; Kohnou K; Kobayashi Y; Takaoka M; Opgenorth TJ; Wessale JL; Matsumura Y
Jpn J Pharmacol; 2000 Apr; 82(4):307-16. PubMed ID: 10875750
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient rats.
Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S86-9. PubMed ID: 11078344
[TBL] [Abstract][Full Text] [Related]
5. Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats.
Itoh M; Takaoka M; Shibata A; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2001 Aug; 298(2):501-7. PubMed ID: 11454911
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelin ET(B) receptors in the renal hemodynamic and excretory responses to big endothelin-1.
Konishi F; Okada Y; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2002 Sep; 451(2):177-84. PubMed ID: 12231389
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.
Matsumura Y; Kuro T; Kobayashi Y; Umekawa K; Ohashi N; Takaoka M
Jpn J Pharmacol; 2000 Sep; 84(1):16-24. PubMed ID: 11043448
[TBL] [Abstract][Full Text] [Related]
8. Salt-sensitive hypertension in endothelin-B receptor-deficient rats.
Gariepy CE; Ohuchi T; Williams SC; Richardson JA; Yanagisawa M
J Clin Invest; 2000 Apr; 105(7):925-33. PubMed ID: 10749572
[TBL] [Abstract][Full Text] [Related]
9. Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction.
Fujii T; Takaoka M; Ohkita M; Matsumura Y
Biol Pharm Bull; 2005 Apr; 28(4):641-5. PubMed ID: 15802802
[TBL] [Abstract][Full Text] [Related]
10. Glomerular endothelin receptors during initiation and maintenance of ischemic acute renal failure in rats.
Wilkes BM; Pearl AR; Mento PF; Maita ME; Macica CM; Girardi EP
Am J Physiol; 1991 Jan; 260(1 Pt 2):F110-8. PubMed ID: 1847009
[TBL] [Abstract][Full Text] [Related]
11. Pre- or post-ischemic treatment with a novel Na+/Ca2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure.
Yamashita J; Itoh M; Kuro T; Kobayashi Y; Ogata M; Takaoka M; Matsumura Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):412-9. PubMed ID: 11160625
[TBL] [Abstract][Full Text] [Related]
12. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
Circulation; 2005 Jan; 111(3):302-9. PubMed ID: 15642760
[TBL] [Abstract][Full Text] [Related]
13. Endothelin up-regulation and localization following renal ischemia and reperfusion.
Wilhelm SM; Simonson MS; Robinson AV; Stowe NT; Schulak JA
Kidney Int; 1999 Mar; 55(3):1011-8. PubMed ID: 10027938
[TBL] [Abstract][Full Text] [Related]
14. KB-R7943, a selective Na+/Ca2+ exchange inhibitor, protects against ischemic acute renal failure in mice by inhibiting renal endothelin-1 overproduction.
Yamashita J; Ogata M; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2001 Mar; 37(3):271-9. PubMed ID: 11243417
[TBL] [Abstract][Full Text] [Related]
15. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function.
Knoll T; Schult S; Birck R; Braun C; Michel MS; Bross S; Juenemann KP; Kirchengast M; Rohmeiss P
J Cardiovasc Pharmacol; 2001 Apr; 37(4):483-8. PubMed ID: 11300661
[TBL] [Abstract][Full Text] [Related]
17. Effects of pre- and post-ischemic treatments with FK409, a nitric oxide donor, on ischemia/reperfusion-induced renal injury and endothelin-1 production in rats.
Nakajima A; Ueda K; Takaoka M; Kurata H; Takayama J; Ohkita M; Matsumura Y
Biol Pharm Bull; 2006 Mar; 29(3):577-9. PubMed ID: 16508172
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide protects against ischemic acute renal failure through the suppression of renal endothelin-1 overproduction.
Kurata H; Takaoka M; Kubo Y; Katayama T; Tsutsui H; Takayama J; Matsumura Y
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S455-8. PubMed ID: 15838347
[TBL] [Abstract][Full Text] [Related]
19. Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor-deficient rats.
Matsumura Y; Kuro T; Konishi F; Takaoka M; Gariepy CE; Yanagisawa M
Br J Pharmacol; 2000 Mar; 129(6):1060-2. PubMed ID: 10725252
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition attenuates renal endothelin-1 production and the development of ischemic acute renal failure in rats.
Takaoka M; Itoh M; Kohyama S; Shibata A; Ohkita M; Matsumura Y
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S225-7. PubMed ID: 11078383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
